Jm. Collard et al., RADICAL ESOPHAGEAL RESECTION FOR ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS, The American journal of surgery, 174(3), 1997, pp. 307-311
BACKGROUND: Esophagectomy with extensive lymph node dissection is the
best way to give Barrett's patients with locally advanced adenocarcino
ma a good chance of cure. MATERIAL AND METHODS: Fifty-five patients un
derwent subtotal (n = 47) or distal (n = 8) esophagectomy for Barrett'
s adenocarcinoma (n = 43) or high-grade dysplasia (HGD) (n = 12), Thir
teen patients (23.6%) never had had any reflux symptom before disclosu
re of the neoplastic lesion, and 20 patients (36.4%) had esophageal sh
ortening. Ro resections (n = 50) included removal of the esophageal tu
be en bloc with the locoregional lymph nodes, RESULTS: An invasive car
cinoma was found in the resected specimen of 4 of the 12 patients oper
ated on for HGD. Two of the 5 patients whose metaplasia was surveyed e
ndoscopically were operated on for an advanced lesion (T2N1, T3N1) bec
ause they had not strictly complied with the proposed schedule, One of
the 4 patients whose HGD was followed up endoscopically until disclos
ure of deeper mucosal invasion had positive lymph nodes at operation,
The prevalence of early lesions (Tis, T1, T2, No) was 7.4% in patients
with tumor-related symptoms versus 85.7% in those having unrelated sy
mptoms (P = 0.0000), which resulted in a 5-year survival rate of 33.8%
and 82.4%, respectively (P = 0.0012), Five-year survival rate after R
o resection made for invasive carcinoma was 59.3% (all cases), 73.1% (
No), 61.5% (less than or equal to 5 positive lymph nodes), and 0% (>5
positive lymph nodes). CONCLUSIONS: High-grade dysplasia is an indicat
ion for esophageal resection. Early detection of the neoplastic transf
ormation of Barrett's metaplasia prior to the onset of obstructive sym
ptoms gives the best chance of cure, Esophagectomy with radical lymph
node clearance is capable of curing a large proportion of the patients
having no or a limited number of metastatic lymph nodes. (C) 1997 by
Excerpta Medica, Inc.